These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. PPAR gamma: an essential role in metabolic control. Fajas L; Debril MB; Auwerx J Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):64-9. PubMed ID: 11383325 [TBL] [Abstract][Full Text] [Related]
28. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Berger J; Bailey P; Biswas C; Cullinan CA; Doebber TW; Hayes NS; Saperstein R; Smith RG; Leibowitz MD Endocrinology; 1996 Oct; 137(10):4189-95. PubMed ID: 8828476 [TBL] [Abstract][Full Text] [Related]
29. The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR gamma and CBP. Mizukami J; Taniguchi T Biochem Biophys Res Commun; 1997 Nov; 240(1):61-4. PubMed ID: 9367882 [TBL] [Abstract][Full Text] [Related]
30. The N-Terminal A/B domain of the thyroid hormone receptor-beta2 isoform influences ligand-dependent recruitment of coactivators to the ligand-binding domain. Tian H; Mahajan MA; Wong CT; Habeos I; Samuels HH Mol Endocrinol; 2006 Sep; 20(9):2036-51. PubMed ID: 16645037 [TBL] [Abstract][Full Text] [Related]
31. [Current topics in the regulation of prostanoids--4. The feedback regulation by PPAR-gamma]. Ohara M; Sawa T Masui; 1999 Feb; 48(2):146-51. PubMed ID: 10087822 [TBL] [Abstract][Full Text] [Related]
32. L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding. Elbrecht A; Chen Y; Adams A; Berger J; Griffin P; Klatt T; Zhang B; Menke J; Zhou G; Smith RG; Moller DE J Biol Chem; 1999 Mar; 274(12):7913-22. PubMed ID: 10075686 [TBL] [Abstract][Full Text] [Related]
33. The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Shalev A; Siegrist-Kaiser CA; Yen PM; Wahli W; Burger AG; Chin WW; Meier CA Endocrinology; 1996 Oct; 137(10):4499-502. PubMed ID: 8828512 [TBL] [Abstract][Full Text] [Related]
34. The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes. Rosenbaum SE; Greenberg AS Mol Endocrinol; 1998 Aug; 12(8):1150-60. PubMed ID: 9717841 [TBL] [Abstract][Full Text] [Related]
35. Ligand-dependent and -independent regulation of PPAR gamma and orphan nuclear receptors. Xu HE; Li Y Sci Signal; 2008 Dec; 1(48):pe52. PubMed ID: 19050303 [TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Schoonjans K; Martin G; Staels B; Auwerx J Curr Opin Lipidol; 1997 Jun; 8(3):159-66. PubMed ID: 9211064 [TBL] [Abstract][Full Text] [Related]
37. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. Reginato MJ; Krakow SL; Bailey ST; Lazar MA J Biol Chem; 1998 Jan; 273(4):1855-8. PubMed ID: 9442016 [TBL] [Abstract][Full Text] [Related]
38. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. Oberfield JL; Collins JL; Holmes CP; Goreham DM; Cooper JP; Cobb JE; Lenhard JM; Hull-Ryde EA; Mohr CP; Blanchard SG; Parks DJ; Moore LB; Lehmann JM; Plunket K; Miller AB; Milburn MV; Kliewer SA; Willson TM Proc Natl Acad Sci U S A; 1999 May; 96(11):6102-6. PubMed ID: 10339548 [TBL] [Abstract][Full Text] [Related]
39. [Significance of PPAR gamma (peroxisome proliferator-activated receptor gamma) in atherosclerosis]. Itoh H; Nakao K Nihon Rinsho; 2001 Feb; 59 Suppl 2():602-16. PubMed ID: 11351658 [No Abstract] [Full Text] [Related]